Muassasa profili
Elbe Klinikum Buxtehude
Kasalxona rejasiga kiritilgan kasalxona · Buxtehude · davlat
Taqqoslash
Toʻshaklar soni: 303. Germaniya kasalxonalarining 75 % undan kichikroq. Mamlakat medianasi: 151.
Bu taqqoslashlar hech bir kasalxona saytida yoʻq. Ular faqat shu sababli mavjudki, bir xil maʼlumotlar bir xil shaklda barcha 2 758 muassasa uchun ochiq.
Maʼlumotlar
- TaʼsischiElbe Klinikum Stade-Buxtehude GmbH
- Taʼsischi turidavlat
- Muassasa turiKasalxona rejasiga kiritilgan kasalxona
- Shoshilinch yordamBazaviy shoshilinch yordam
- Maxsus modullaryoʻq
- Toʻshaklar303
- Boʻlimlar4
- Telefon+49 4161 703-0
- E-pochtainfo@elbekliniken.de
Boʻlimlar
§ 301 SGB V boʻyicha nomlar va toʻshaklar soni, rasmiy reyestrdan aynan olingan.
| Boʻlimlar | Toʻshaklar |
|---|---|
| Ichki kasalliklarInnere Medizin | 116 |
| Umumiy jarrohlikAllgemeine Chirurgie | 115 |
| Dermatologiya va allergologiyaDermatologie | 41 |
| GinekologiyaFrauenheilkunde und Geburtshilfe | 31 |
| Jami | 303 |
Nashrlar
Muallif mansubligida ushbu muassasani ko'rsatgan ilmiy nashrlar: 47 · dan beri 2008
Muallif mansubligiga ko'ra ixtisoslashgan nashrlar – davolash natijasi yoki muassasa sifati haqida da'vo emas. MedVici Health hozircha saraton bilan bog'liq nashrlarni ko'rsatmaydi.
Eng yangilari:
- CD160 mediated NK cell activation shapes host defense against acute Trypanosoma cruzi infection in the skinFrontiers in immunology · 2026
- Clinical and molecular improvements in pediatric patients with atopic dermatitis treated with dupilumab: An analysis from the TREATKids registryThe Journal of investigative dermatology · 2026
- Single-use negative pressure therapy for prevention of wound healing disorders for primarily closed incisions : International consensus and practical recommendations for GermanyChirurgie (Heidelberg, Germany) · 2026 · Klinik tavsiyanoma
- Keratinocyte Priming by Staphylococcus aureus Reduces HSV-1 SusceptibilityAllergy · 2026
- Performance of omalizumab in patients with mast cell-mediated angioedema with and without whealsThe journal of allergy and clinical immunology. In practice · 2026
- Klinisches und immunpathologisches Spektrum des Immunglobulin‐M‐Pemphigoids: eine multizentrische FallserieJDDG Journal der Deutschen Dermatologischen Gesellschaft · 2025
- Nivolumab vs placebo dans le traitement adjuvant des patients atteints d’un mélanome de stade IIB/C : résultats à 4 ans de l’étude CheckMate 76K (CM 76K)Annales de Dermatologie et de Vénéréologie - FMC · 2025
- Spectrum and Impact of Reported Side Effects of Omalizumab in Patients With Chronic Urticaria: A Long-Term Multicentre Real-World StudyClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2025 · Tadqiqot
- Nivolumab vs placebo dans le traitement adjuvant des patients atteints d’un mélanome de stade IIB/C : résultats à 3 ans de l’étude CheckMate 76K (CM 76K)Annales de Dermatologie et de Vénéréologie - FMC · 2024
- Type 2 Immune-Dominant Endotype Is Not Associated With Increased Responsiveness to Dupilumab Treatment in Adult Atopic Dermatitis PatientsClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2024
MedVici Media'dagi barcha yozuvlar
Moslashtirish nashrning muallif mansubligi bo'yicha amalga oshiriladi. Ma'lumotlar: PubMed (U.S. National Library of Medicine) va OpenAlex. Ro'yxat muassasani ham, uning davolash usullarini ham baholamaydi.